BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Crippa S, Bassi C, Salvia R, Malleo G, Marchegiani G, Rebours V, Levy P, Partelli S, Suleiman SL, Banks PA. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis. Gut. 2016; Epub ahead of print. [PMID: 26743012 DOI: 10.1136/gutjnl-2015-310162] [Cited by in Crossref: 120] [Cited by in F6Publishing: 103] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Basnayake O, Wijerathne P, Jayarajah U, Fernandopulle N, Sivaganesh S. Total Pancreatectomy for Malignant Intraductal Papillary Mucinous Neoplasm (IPMN) Complicated by Gastropancreatic Fistulae. Case Rep Surg 2020;2020:8547526. [PMID: 32274240 DOI: 10.1155/2020/8547526] [Reference Citation Analysis]
2 Amodio A, De Marchi G, de Pretis N, Crinò SF, D'Onofrio M, Gabbrielli A, Ciccocioppo R, Frulloni L. Painless chronic pancreatitis. Dig Liver Dis 2020;52:1333-7. [PMID: 32921601 DOI: 10.1016/j.dld.2020.08.040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
3 Cui M, Hu Y, You L, Liu Q, A L, Wu W, Liao Q, Zhao Y. A bibliometric study on pancreatic cystic disease research. Journal of Pancreatology 2019;2:43-7. [DOI: 10.1097/jp9.0000000000000015] [Reference Citation Analysis]
4 Larson A, Kwon RS. Natural History of Pancreatic Cysts. Dig Dis Sci 2017;62:1770-7. [PMID: 28315034 DOI: 10.1007/s10620-017-4542-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 Hata T, Dal Molin M, Hong SM, Tamura K, Suenaga M, Yu J, Sedogawa H, Weiss MJ, Wolfgang CL, Lennon AM, Hruban RH, Goggins MG. Predicting the Grade of Dysplasia of Pancreatic Cystic Neoplasms Using Cyst Fluid DNA Methylation Markers. Clin Cancer Res. 2017;23:3935-3944. [PMID: 28148542 DOI: 10.1158/1078-0432.ccr-16-2244] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
6 Hua J, Zhang B, Yang XJ, Zhang YY, Wei MY, Liang C, Meng QC, Liu J, Yu XJ, Xu J, Shi S. Validation and head-to-head comparison of four models for predicting malignancy of intraductal papillary mucinous neoplasm of the pancreas: A study based on endoscopic ultrasound findings. World J Gastrointest Oncol 2019; 11(11): 1043-1053 [PMID: 31798784 DOI: 10.4251/wjgo.v11.i11.1043] [Reference Citation Analysis]
7 Chhoda A, Yousaf MN, Madhani K, Aslanian H, Jamidar PA, Suarez AL, Salem RR, Muniraj T, Kunstman JW, Farrell JJ. Comorbidities Drive the Majority of Overall Mortality in Low-Risk Mucinous Pancreatic Cysts Under Surveillance. Clin Gastroenterol Hepatol 2022;20:631-640.e1. [PMID: 33309984 DOI: 10.1016/j.cgh.2020.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Marchegiani G, Andrianello S, Morbin G, Secchettin E, D'Onofrio M, De Robertis R, Malleo G, Bassi C, Salvia R. Importance of main pancreatic duct dilatation in IPMN undergoing surveillance. Br J Surg. 2018;105:1825-1834. [PMID: 30106195 DOI: 10.1002/bjs.10948] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
9 Aronsson L, Andersson R, Ansari D. Intraductal papillary mucinous neoplasm of the pancreas – epidemiology, risk factors, diagnosis, and management. Scandinavian Journal of Gastroenterology 2017;52:803-15. [DOI: 10.1080/00365521.2017.1318948] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
10 Aunan JR, Jamieson NB, Søreide K. Observation or resection of pancreatic intraductal papillary mucinous neoplasm: An ongoing tug of war. World J Gastrointest Oncol 2019; 11(12): 1092-1100 [PMID: 31908715 DOI: 10.4251/wjgo.v11.i12.1092] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
11 Marchegiani G, Andrianello S, Perri G, Bonamini D, De Robertis R, Malleo G, Bassi C, Salvia R. Vanishing Pancreatic Cysts during Follow-Up: Another Step Towards De-Emphasizing Cyst Size as a Major Clinical Predictor of Malignancy. Dig Surg 2018;35:508-13. [PMID: 29232660 DOI: 10.1159/000485199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
12 Li J, Wei T, Zhang J, Liang T. Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Review of Their Genetic Characteristics and Mouse Models. Cancers (Basel) 2021;13:5296. [PMID: 34771461 DOI: 10.3390/cancers13215296] [Reference Citation Analysis]
13 Wu YHA, Oba A, Beaty L, Colborn KL, Rodriguez Franco S, Harnke B, Meguid C, Negrini D, Valente R, Ahrendt S, Schulick RD, Del Chiaro M. Ductal Dilatation of ≥5 mm in Intraductal Papillary Mucinous Neoplasm Should Trigger the Consideration for Pancreatectomy: A Meta-Analysis and Systematic Review of Resected Cases. Cancers (Basel) 2021;13:2031. [PMID: 33922344 DOI: 10.3390/cancers13092031] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Gaujoux S, Belghiti J. Pancreatic cancer is still waiting for the big leap forward. La Presse Médicale 2019;48:e111-2. [DOI: 10.1016/j.lpm.2019.02.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Tanaka M, Fernández-del Castillo C, Kamisawa T, Jang JY, Levy P, Ohtsuka T, Salvia R, Shimizu Y, Tada M, Wolfgang CL. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017;17:738-53. [DOI: 10.1016/j.pan.2017.07.007] [Cited by in Crossref: 574] [Cited by in F6Publishing: 463] [Article Influence: 114.8] [Reference Citation Analysis]
16 Rossi RE, Massironi S. Intraductal papillary mucinous neoplasms of the pancreas: a clinical challenge. Expert Rev Gastroenterol Hepatol 2018;12:1123-33. [PMID: 30264593 DOI: 10.1080/17474124.2018.1530111] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
17 Kromrey ML, Bülow R, Hübner J, Paperlein C, Lerch MM, Ittermann T, Völzke H, Mayerle J, Kühn JP. Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut 2018;67:138-45. [PMID: 28877981 DOI: 10.1136/gutjnl-2016-313127] [Cited by in Crossref: 89] [Cited by in F6Publishing: 70] [Article Influence: 17.8] [Reference Citation Analysis]
18 Hoda RS, Pitman MB. Pancreatic Cytology. Surgical Pathology Clinics 2018;11:563-88. [DOI: 10.1016/j.path.2018.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
19 Tanaka M, Heckler M, Liu B, Heger U, Hackert T, Michalski CW. Cytologic Analysis of Pancreatic Juice Increases Specificity of Detection of Malignant IPMN-A Systematic Review. Clin Gastroenterol Hepatol. 2019;. [PMID: 30630102 DOI: 10.1016/j.cgh.2018.12.034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
20 European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67:789-804. [PMID: 29574408 DOI: 10.1136/gutjnl-2018-316027] [Cited by in Crossref: 380] [Cited by in F6Publishing: 283] [Article Influence: 95.0] [Reference Citation Analysis]
21 Duconseil P, Adham M, Sauvanet A, Autret A, Périnel J, Chiche L, Mabrut JY, Tuech JJ, Mariette C, Turrini O. Fukuoka-Negative Branch-Duct IPMNs: When to Worry? A Study from the French Surgical Association (AFC). Ann Surg Oncol 2018;25:1017-25. [PMID: 29392508 DOI: 10.1245/s10434-017-6318-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
22 Farrell JJ. Editorial: Stopping Pancreatic Cyst Surveillance? Am J Gastroenterol 2017;112:1162-4. [PMID: 28725064 DOI: 10.1038/ajg.2017.163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
23 Sakai A, Masuda A, Eguchi T, Anami T, Nishi K, Furumatsu K, Okabe Y, Kakuyama S, Sato Y, Nishioka C, Sanuki T, Yagi Y, Kobayashi T, Shiomi H, Kodama Y. Clinical outcome of conservatively managed pancreatic intraductal papillary mucinous neoplasms with mural nodules and main duct dilation. J Gastroenterol 2021;56:285-92. [PMID: 33112991 DOI: 10.1007/s00535-020-01739-y] [Reference Citation Analysis]
24 Giuffrida P, Biagiola D, Ardiles V, Uad P, Palavecino M, de Santibañes M, Clariá RS, Pekolj J, de Santibañes E, Mazza O. Long-term follow-up of Branch-Duct Intraductal Papillary Mucinous Neoplasms with negative Sendai Criteria: the therapeutic challenge of patients who convert to positive Sendai Criteria. HPB (Oxford) 2021;23:290-300. [PMID: 32709558 DOI: 10.1016/j.hpb.2020.06.011] [Reference Citation Analysis]
25 Bouquot M, Gaujoux S, Cauchy F, Birnbaum D, Dokmak S, Levy P, Soubrane O, Sauvanet A. Pancreatectomy for pancreatic incidentaloma: What are the risks? Pancreatology 2018;18:114-21. [DOI: 10.1016/j.pan.2017.11.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Gausman V, Kandel P, Van Riet PA, Moris M, Kayal M, Do C, Poneros JM, Sethi A, Gress FG, Schrope BA, Luk L, Hecht E, Jovani M, Bruno MJ, Cahen DL, Wallace MB, Gonda TA. Predictors of Progression Among Low-Risk Intraductal Papillary Mucinous Neoplasms in a Multicenter Surveillance Cohort. Pancreas 2018;47:471-6. [PMID: 29521942 DOI: 10.1097/MPA.0000000000001027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
27 Surci N, Ramera M, Borin A, Marchegiani G, Salvia R, Bassi C; SPaRo Group. Implementation of a strategic preoperative surgical meeting to improve the level of care at a high-volume pancreatic center: a before–after analysis of 1000 consecutive cases. Updates Surg 2020;72:155-61. [DOI: 10.1007/s13304-020-00707-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
28 Hata T, Dal Molin M, McGregor-Das A, Song TJ, Wolfgang C, Eshleman JR, Hruban RH, Goggins M. Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid. J Mol Diagn 2018;20:46-55. [PMID: 29229290 DOI: 10.1016/j.jmoldx.2017.09.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
29 Gaujoux S, Cros J. ASO Author Reflections: What Will Be the Future of IPMN Management? Ann Surg Oncol 2019;26:743-4. [PMID: 31552617 DOI: 10.1245/s10434-019-07858-y] [Reference Citation Analysis]
30 Quero G, Pecorelli N, Paiella S, Fiorillo C, Petrone MC, Capretti G, Laterza V, De Sio D, Menghi R, Kauffmann E, Nobile S, Butturini G, Ferrari G, Rosa F, Coratti A, Casadei R, Mazzaferro V, Boggi U, Zerbi A, Salvia R, Falconi M, Alfieri S. Pancreaticoduodenectomy in octogenarians: The importance of "biological age" on clinical outcomes. Surg Oncol 2021;40:101688. [PMID: 34844071 DOI: 10.1016/j.suronc.2021.101688] [Reference Citation Analysis]
31 Hua J, Zhang B, Yang X, Zhang Y, Wei M, Liang C, Meng Q, Liu J, Yu X, Xu J, Shi S. Validation and head-to-head comparison of four models for predicting malignancy of intraductal papillary mucinous neoplasm of the pancreas: A study based on endoscopic ultrasound findings. WJGO 2019;11:1043-53. [DOI: 10.4251/wjo.v11.i11.1043] [Reference Citation Analysis]
32 D'Haese JG, Werner J. Surgery of Cystic Tumors of the Pancreas - Why, When, and How? Visc Med 2018;34:206-10. [PMID: 30182025 DOI: 10.1159/000489234] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
33 Gerry JM, Poultsides GA. Surgical Management of Pancreatic Cysts: A Shifting Paradigm Toward Selective Resection. Dig Dis Sci. 2017;62:1816-1826. [PMID: 28421458 DOI: 10.1007/s10620-017-4570-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
34 Hanada K, Amano H, Abe T. Early diagnosis of pancreatic cancer: Current trends and concerns. Ann Gastroenterol Surg 2017;1:44-51. [PMID: 29863166 DOI: 10.1002/ags3.12004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
35 McNicholas BA, Kotaro Y, Martin W, Sharma A, Kamath PS, Edwards ME, Kremers WK, Chari ST, Torres VE, Harris PC, Takahashi N, Hogan MC. Pancreatic Cysts and Intraductal Papillary Mucinous Neoplasm in Autosomal Dominant Polycystic Kidney Disease. Pancreas 2019;48:698-705. [PMID: 31091218 DOI: 10.1097/MPA.0000000000001306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Andrianello S, Falconi M, Salvia R, Crippa S, Marchegiani G. Surveillance of Cystic Lesions of the Pancreas: Whom and How to Survey? Visc Med 2018;34:202-5. [PMID: 30140686 DOI: 10.1159/000489240] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Kashiwagi K, Minami K, Seino T, Hirata K, Iwasaki E, Inoue N, Iwao Y, Kanai T. Pancreatic fat content may increase the risk of imaging progression in low-risk branch duct intraductal papillary mucinous neoplasm. J Dig Dis 2019;20:557-62. [PMID: 31322828 DOI: 10.1111/1751-2980.12801] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
38 Kawakami S, Fukasawa M, Shimizu T, Ichikawa S, Sato T, Takano S, Kadokura M, Shindo H, Takahashi E, Hirose S, Fukasawa Y, Hayakawa H, Nakayama Y, Yamaguchi T, Inoue T, Maekawa S, Kawaida H, Motosugi U, Onishi H, Enomoto N. Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm. Medicine (Baltimore) 2019;98:e18039. [PMID: 31764824 DOI: 10.1097/MD.0000000000018039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
39 Del Chiaro M, Beckman R, Ateeb Z, Orsini N, Rezaee N, Manos L, Valente R, Yuan C, Ding D, Margonis GA, Yin L, Cameron JL, Makary MA, Burkhart RA, Weiss MJ, He J, Arnelo U, Yu J, Wolfgang CL. Main Duct Dilatation Is the Best Predictor of High-grade Dysplasia or Invasion in Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg. 2019;. [PMID: 30672797 DOI: 10.1097/sla.0000000000003174] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 12.5] [Reference Citation Analysis]
40 Salla C, Karvouni E, Nikas I, Ikonomakis A, Konstantinou P, Karoumpalis I, Sepsa A, Papaparaskeva K, Tsopanomichalou M, Georgiadou D, Kostopoulou A, Tsiotos G, Theocharis S, Sergentanis TN, Politi E. Imaging and Cytopathological Criteria Indicating Malignancy in Mucin-Producing Pancreatic Neoplasms: A Series of 68 Histopathologically Confirmed Cases. Pancreas 2018;47:1283-9. [PMID: 30308535 DOI: 10.1097/MPA.0000000000001182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Maggi G, Guarneri G, Gasparini G, Fogliati A, Partelli S, Falconi M, Crippa S. Pancreatic cystic neoplasms: What is the most cost-effective follow-up strategy? Endosc Ultrasound 2018;7:319-22. [PMID: 30323161 DOI: 10.4103/eus.eus_44_18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
42 Schmitz D, Kazdal D, Allgäuer M, Trunk M, Vornhusen S, Nahm AM, Doll M, Weingärtner S, Endris V, Penzel R, Kirchner M, Brandt R, Neumann O, Sültmann H, Budczies J, Kienle P, Magdeburg R, Hetjens S, Schirmacher P, Bergmann F, Rudi J, Stenzinger A, Volckmar AL. KRAS/GNAS-testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound-guided workup of suspected mucinous neoplasms of the pancreas. Genes Chromosomes Cancer 2021;60:489-97. [PMID: 33686791 DOI: 10.1002/gcc.22946] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Poruk KE, Griffin J, Makary MA, He J, Cameron JL, Weiss MJ, Wood LD, Goggins M, Wolfgang CL. Blood Type as a Predictor of High-Grade Dysplasia and Associated Malignancy in Patients with Intraductal Papillary Mucinous Neoplasms. J Gastrointest Surg 2019;23:477-83. [PMID: 30187322 DOI: 10.1007/s11605-018-3795-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
44 Hocke M, Braden B, Jenssen C, Dietrich CF. Present status and perspectives of endosonography 2017 in gastroenterology. Korean J Intern Med 2018;33:36-63. [PMID: 29161800 DOI: 10.3904/kjim.2017.212] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
45 Crippa S, Piccioli A, Salandini MC, Cova C, Aleotti F, Falconi M. Treatment of branch-duct intraductal papillary mucinous neoplasms of the pancreas: state of the art. Updates Surg 2016;68:265-71. [PMID: 27502606 DOI: 10.1007/s13304-016-0386-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
46 Brunner M, Belyaev O, Bösch F, Müller-Debus CF, Radulova-Mauersberger O, Wellner UF, Keck T, Uhl W, Werner J, Witzigmann H, Grützmann R. [Indications for the Surgical Management of Pancreatic Cystic Lesions]. Zentralbl Chir 2020;145:344-53. [PMID: 32498095 DOI: 10.1055/a-1158-9536] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Hirono S, Kawai M, Okada K, Miyazawa M, Shimizu A, Kitahata Y, Ueno M, Yanagisawa A, Yamaue H. Long-term surveillance is necessary after operative resection for intraductal papillary mucinous neoplasm of the pancreas. Surgery 2016;160:306-17. [DOI: 10.1016/j.surg.2016.04.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
48 Bartel MJ, Raimondo M. Endoscopic Management of Pancreatic Cysts. Dig Dis Sci 2017;62:1808-15. [PMID: 28315030 DOI: 10.1007/s10620-017-4544-8] [Reference Citation Analysis]
49 Salvia R, Burelli A, Perri G, Marchegiani G. State-of-the-art surgical treatment of IPMNs. Langenbecks Arch Surg 2021. [PMID: 34738168 DOI: 10.1007/s00423-021-02349-9] [Reference Citation Analysis]
50 Pak LM, D'Angelica MI, DeMatteo RP, Kingham TP, Balachandran VP, Jarnagin WR, Allen PJ. Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas. J Gastrointest Surg 2017;21:1599-605. [PMID: 28516310 DOI: 10.1007/s11605-016-3338-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
51 Del Chiaro M, Valente R, Wolfgang C. Response to Comment on “Main Duct Dilatation is the Best Predictor of High-grade Dysplasia or Invasion in Intraductal Papillary Mucinous Neoplasms of the Pancreas”. Annals of Surgery 2019;270:e109-10. [DOI: 10.1097/sla.0000000000003677] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
52 Aronsson L, Ansari D, Andersson B, Persson U, Fridhammar A, Andersson R. Intraductal papillary mucinous neoplasms of the pancreas – a cost-effectiveness analysis of management strategies for the branch-duct subtype. HPB 2018;20:1206-14. [DOI: 10.1016/j.hpb.2018.06.1801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
53 Vanella G, Crippa S, Archibugi L, Arcidiacono PG, Delle Fave G, Falconi M, Capurso G. Meta-analysis of mortality in patients with high-risk intraductal papillary mucinous neoplasms under observation. Br J Surg. 2018;105:328-338. [PMID: 29405253 DOI: 10.1002/bjs.10768] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
54 Brugge WR. Pancreatic cyst surveillance: Threat or opportunity? Gastrointestinal Endoscopy 2016;83:1118-20. [DOI: 10.1016/j.gie.2016.02.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
55 Lin KW, Ang TL, Li JW. Role of artificial intelligence in early detection and screening for pancreatic adenocarcinoma. Artif Intell Med Imaging 2022; 3(2): 21-32 [DOI: 10.35711/aimi.v3.i2.21] [Reference Citation Analysis]
56 Caravati A, Andrianello S, Pollini T, Biancotto M, Balduzzi A, Malleo G, Salvia R, Marchegiani G. Branch Duct Intraductal Papillary Mucinous Neoplasms: Recommendations for Follow-Up and Surgery. Scand J Surg 2020;109:34-41. [PMID: 32009571 DOI: 10.1177/1457496919900414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Dal borgo C, Perri G, Borin A, Marchegiani G, Salvia R, Bassi C. The Clinical Management of Main Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas. Dig Surg 2019;36:104-10. [DOI: 10.1159/000486869] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
58 Keane MG, Dadds HR, El Sayed G, Luong TV, Davidson BR, Fusai GK, Thorburn D, Pereira SP. Clinical and radiological features that predict malignant transformation in cystic lesions of the pancreas: a retrospective case note review. AMRC Open Res 2020;1:4. [PMID: 32322783 DOI: 10.12688/amrcopenres.12860.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Gaujoux S, Parvanescu A, Cesaretti M, Silve C, Bieche I, Rebours V, Lévy P, Sauvanet A, Cros J. GNAS but Not Extended RAS Mutations Spectrum are Associated with a Better Prognosis in Intraductal Pancreatic Mucinous Neoplasms. Ann Surg Oncol 2019;26:2640-50. [DOI: 10.1245/s10434-019-07389-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
60 Lensing RJ, Bipat S. Incidences of Pancreatic Malignancy and Mortality in Patients With Untreated Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Surveillance: A Systematic Review. Pancreas. 2017;46:1098-1110. [PMID: 28902778 DOI: 10.1097/mpa.0000000000000907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
61 Hoda RS, Lu R, Arpin RN, Rosenbaum MW, Pitman MB. Risk of malignancy in pancreatic cysts with cytology of high-grade epithelial atypia. Cancer Cytopathology 2018;126:773-81. [DOI: 10.1002/cncy.22035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
62 Das KK, Mullady DK. Main Pancreatic Duct Dilation in IPMN: When (and Where) to Get "Worried"? Clin Gastroenterol Hepatol 2021:S1542-3565(21)00151-8. [PMID: 33581356 DOI: 10.1016/j.cgh.2021.02.017] [Reference Citation Analysis]
63 Marchegiani G, Salvia R; Verona EBM 2020 on IPMN. Guidelines on Pancreatic Cystic Neoplasms: Major Inconsistencies With Available Evidence and Clinical Practice- Results From an International Survey. Gastroenterology 2021;160:2234-8. [PMID: 33609506 DOI: 10.1053/j.gastro.2021.02.026] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Pulvirenti A, Margonis GA, Morales-Oyarvide V, McIntyre CA, Lawrence SA, Goldman DA, Gonen M, Weiss MJ, Ferrone CR, He J, Brennan MF, Cameron JL, Lillemoe KD, Kingham TP, Balachandran V, Qadan M, D'Angelica MI, Jarnagin WR, Wolfgang CL, Castillo CF, Allen PJ. Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study. Ann Surg 2019. [PMID: 31804389 DOI: 10.1097/SLA.0000000000003703] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
65 Bournet B, Vignolle-Vidoni A, Grand D, Roques C, Breibach F, Cros J, Muscari F, Carrère N, Selves J, Cordelier P, Buscail L. Endoscopic ultrasound-guided fine-needle aspiration plus KRAS and GNAS mutation in malignant intraductal papillary mucinous neoplasm of the pancreas. Endosc Int Open 2016;4:E1228-35. [PMID: 27995180 DOI: 10.1055/s-0042-117216] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
66 Hipp J, Mohamed S, Pott J, Sick O, Makowiec F, Hopt UT, Fichtner-Feigl S, Wittel UA. Management and outcomes of intraductal papillary mucinous neoplasms. BJS Open 2019;3:490-9. [PMID: 31388641 DOI: 10.1002/bjs5.50156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
67 Hipp J, Rist L, Chikhladze S, Ruess DA, Fichtner-Feigl S, Wittel UA. Perioperative risk of pancreatic head resection-nomogram-based prediction of severe postoperative complications as a decisional aid for clinical practice. Langenbecks Arch Surg 2022. [PMID: 35320379 DOI: 10.1007/s00423-021-02426-z] [Reference Citation Analysis]
68 Pergolini I, Sahora K, Ferrone CR, Morales-Oyarvide V, Wolpin BM, Mucci LA, Brugge WR, Mino-Kenudson M, Patino M, Sahani DV, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center. Gastroenterology 2017;153:1284-1294.e1. [PMID: 28739282 DOI: 10.1053/j.gastro.2017.07.019] [Cited by in Crossref: 102] [Cited by in F6Publishing: 78] [Article Influence: 20.4] [Reference Citation Analysis]
69 Marchegiani G, Andrianello S, Perri G, Pollini T, Caravati A, Secchettin E, Malleo G, Bassi C, Salvia R. The role of age in pancreatic intraductal papillary mucinous neoplasms of the pancreas: Same risk of death but different implications for management. Digestive and Liver Disease 2018;50:1327-33. [DOI: 10.1016/j.dld.2018.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
70 Scholten L, Latenstein AE, Aalfs CM, Bruno MJ, Busch OR, Bonsing BA, Koerkamp BG, Molenaar IQ, Ubbink DT, van Hooft JE, Fockens P, Glas J, DeVries JH, Besselink MG; Dutch Pancreatic Cancer Group. Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic review and shared decision-making programme using decision tables. United European Gastroenterol J 2020;8:865-77. [PMID: 32703081 DOI: 10.1177/2050640620945534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
71 Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, Bassi C, Carrato A, Farrell J, Fishman EK, Fockens P, Gress TM, van Hooft JE, Hruban RH, Kastrinos F, Klein A, Lennon AM, Lucas A, Park W, Rustgi A, Simeone D, Stoffel E, Vasen HFA, Cahen DL, Canto MI, Bruno M;  International Cancer of the Pancreas Screening (CAPS) consortium. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 2020;69:7-17. [PMID: 31672839 DOI: 10.1136/gutjnl-2019-319352] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 31.0] [Reference Citation Analysis]
72 Amico EC, Salgado CTS, Alves JR, Liguori AAL, Sousa RL. Non-inflammatory pancreatic cysts: from diagnosis to treatment (97 cases series). Rev Col Bras Cir 2021;48:e20213009. [PMID: 34816881 DOI: 10.1590/0100-6991e-20213009] [Reference Citation Analysis]
73 Del Chiaro M, Ateeb Z, Hansson MR, Rangelova E, Segersvärd R, Kartalis N, Ansorge C, Löhr MJ, Arnelo U, Verbeke C. Survival Analysis and Risk for Progression of Intraductal Papillary Mucinous Neoplasia of the Pancreas (IPMN) Under Surveillance: A Single-Institution Experience. Ann Surg Oncol 2017;24:1120-6. [PMID: 27822633 DOI: 10.1245/s10434-016-5661-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
74 Han Y, Jang JY, Oh MY, Kim HS, Byun Y, Kang JS, Kim SH, Lee KB, Kim H, Kwon W. Natural history and optimal treatment strategy of intraductal papillary mucinous neoplasm of the pancreas: Analysis using a nomogram and Markov decision model. J Hepatobiliary Pancreat Sci 2021;28:131-42. [PMID: 33283481 DOI: 10.1002/jhbp.878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
75 Canakis A, Lee LS. State-of-the-Art Update of Pancreatic Cysts. Dig Dis Sci 2021. [PMID: 34383196 DOI: 10.1007/s10620-021-07084-1] [Reference Citation Analysis]
76 Crippa S, Pezzilli R, Capurso G, Ruffo G, Falconi M. Response to Malleo et al. Am J Gastroenterol 2017;112:1481-2. [PMID: 28874865 DOI: 10.1038/ajg.2017.204] [Reference Citation Analysis]
77 Marinelli V, Secchettin E, Andrianello S, Moretti C, Donvito S, Marchegiani G, Esposito A, Casetti L, Salvia R. Psychological distress in patients under surveillance for intraductal papillary mucinous neoplasms of the pancreas: The "Sword of Damocles" effect calls for an integrated medical and psychological approach a prospective analysis. Pancreatology 2020;20:505-10. [PMID: 31948794 DOI: 10.1016/j.pan.2020.01.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
78 Blackford AL, Canto MI, Klein AP, Hruban RH, Goggins M. Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis. J Natl Cancer Inst 2020;112:1162-9. [PMID: 31958122 DOI: 10.1093/jnci/djaa004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 21.0] [Reference Citation Analysis]
79 Ricci C, Ingaldi C, Migliori M, Pagano N, Santini D, Alberici L, Serra C, Calculli L, Di Marco M, Minni F, Casadei R. What is the Outcome of Patients Affected by Intraductal Papillary Mucinous Neoplasms Without High-Risk Stigmata?: A Single-Center Retrospective Study. Pancreas 2019;48:1167-74. [PMID: 31593009 DOI: 10.1097/MPA.0000000000001388] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
80 Macgregor-das A, Goggins M. Diagnostic Biomarkers. In: Neoptolemos JP, Urrutia R, Abbruzzese JL, Büchler MW, editors. Pancreatic Cancer. New York: Springer; 2018. pp. 659-80. [DOI: 10.1007/978-1-4939-7193-0_56] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Fong ZV, Fernández-del Castillo C. Intraductal Papillary Mucinous Neoplasm of the Pancreas. Surgical Clinics of North America 2016;96:1431-45. [DOI: 10.1016/j.suc.2016.07.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
82 Laquière A, Lagarde A, Napoléon B, Bourdariat R, Atkinson A, Donatelli G, Pol B, Lecomte L, Curel L, Urena-Campos R, Helbert T, Valantin V, Mithieux F, Buono JP, Grandval P, Olschwang S. Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue. World J Gastroenterol 2019; 25(36): 5530-5542 [PMID: 31576098 DOI: 10.3748/wjg.v25.i36.5530] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Pérez-Cuadrado-Robles E, Uribarri-González L, Borbath I, Vila JJ, López-López S, Deprez PH. Risk of advanced lesions in patients with branch-duct IPMN and relative indications for surgery according to European evidence-based guidelines. Dig Liver Dis 2019;51:882-6. [PMID: 30591368 DOI: 10.1016/j.dld.2018.11.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
84 Lazzarin G, Romano L, Schietroma M, Carlei F, Giuliani A. Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas: an Update in Definition, Time to Progression, and Surgical Management. Indian J Surg. [DOI: 10.1007/s12262-022-03394-4] [Reference Citation Analysis]
85 Crippa S, Aleotti F, Longo E, Belfiori G, Partelli S, Tamburrino D, Di Salvo F, De Cobelli F, Romano L, Arcidiacono PG, Petrone MC, Zamboni G, Lena MS, Doglioni C, Falconi M. Main Duct Thresholds for Malignancy Are Different in Intraductal Papillary Mucinous Neoplasms of the Pancreatic Head and Body-Tail. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31724-9. [PMID: 33385536 DOI: 10.1016/j.cgh.2020.12.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Tsumura A, Hirono S, Kawai M, Okada KI, Miyazawa M, Kitahata Y, Kobayashi R, Hayami S, Ueno M, Yanagisawa A, Yamaue H. Surgical indication for intraductal papillary mucinous neoplasm without mural nodule ≥5 mm. Surgery 2021;169:388-95. [PMID: 32859391 DOI: 10.1016/j.surg.2020.07.005] [Reference Citation Analysis]
87 Mukewar S, de Pretis N, Aryal-Khanal A, Ahmed N, Sah R, Enders F, Larson JJ, Levy MJ, Takahashi N, Topazian M, Pearson R, Vege SS, Chari ST. Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms. Gut. 2017;66:1811-1817. [PMID: 27390303 DOI: 10.1136/gutjnl-2016-311615] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 9.7] [Reference Citation Analysis]
88 Kolb JM, Argiriadi P, Lee K, Liu X, Bagiella E, Gupta S, Lucas AL, Kim MK, Kumta NA, Nagula S, Sarpel U, DiMaio CJ. Higher Growth Rate of Branch Duct Intraductal Papillary Mucinous Neoplasms Associates With Worrisome Features. Clin Gastroenterol Hepatol 2018;16:1481-7. [PMID: 29535058 DOI: 10.1016/j.cgh.2018.02.050] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
89 Brunner M, Weber GF, Kersting S, Grützmann R. [Branch duct intraductal papillary mucinous neoplasm - contra resection]. Chirurg 2017;88:918-26. [PMID: 28871376 DOI: 10.1007/s00104-017-0495-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
90 Han Y, Lee H, Kang JS, Kim JR, Kim HS, Lee JM, Lee KB, Kwon W, Kim SW, Jang JY. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size. Gastroenterology. 2018;154:576-584. [PMID: 29074452 DOI: 10.1053/j.gastro.2017.10.013] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 11.0] [Reference Citation Analysis]
91 Crippa S, Fogliati A, Valente R, Sadr-Azodi O, Arnelo U, Capurso G, Halimi A, Partelli S, Ateeb Z, Arcidiacono PG, Lohr JM, Falconi M, Del Chiaro M. A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines. Dig Liver Dis 2021;53:998-1003. [PMID: 33846103 DOI: 10.1016/j.dld.2021.03.009] [Reference Citation Analysis]
92 Muniraj T, Aslanian HR. Long-Term Follow-Up of Low-Risk Branch Duct IPMNs of the Pancreas: Watch for Main Pancreatic Duct Dilatation, and for How Long? Clin Transl Gastroenterol 2018;9:198. [PMID: 30353003 DOI: 10.1038/s41424-018-0065-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
93 Farrell JJ. Does Pancreatic Cyst Stability Justify Stopping Intraductal Papillary Mucinous Neoplasm Surveillance? Gastroenterology 2020;158:44-6. [PMID: 31738923 DOI: 10.1053/j.gastro.2019.11.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
94 Regenet N, Sauvanet A, Muscari F, Meunier B, Mariette C, Adham M, Moutardier V, Delpero J, Regimbeau J, Pessaux P, Paye F, Sa Cunha A, Ansquer C. The value of 18F-FDG positron emission tomography to differentiate benign from malignant intraductal papillary mucinous neoplasms: A prospective multicenter study. Journal of Visceral Surgery 2020;157:387-94. [DOI: 10.1016/j.jviscsurg.2020.01.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
95 Hisada Y, Nagata N, Imbe K, Takasaki Y, Sekine K, Tajima T, Yanase M, Fujimoto K, Akiyama J, Uemura N. Natural history of intraductal papillary mucinous neoplasm and non-neoplastic cyst: long-term imaging follow-up study. J Hepatobiliary Pancreat Sci 2017;24:401-8. [PMID: 28512773 DOI: 10.1002/jhbp.463] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
96 Marchegiani G, Andrianello S, Crippa S, Pollini T, Belfiori G, Gozzini L, Cassalia F, Caravati A, Luchini C, Doglioni C, Bassi C, Falconi M, Salvia R. Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance. Br J Surg 2021:znab131. [PMID: 34059873 DOI: 10.1093/bjs/znab131] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Suenaga M, Yu J, Shindo K, Tamura K, Almario JA, Zaykoski C, Witmer PD, Fesharakizadeh S, Borges M, Lennon AM, Shin EJ, Canto MI, Goggins M. Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance. Clin Cancer Res. 2018;24:2963-2974. [PMID: 29301828 DOI: 10.1158/1078-0432.ccr-17-2463] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
98 van Huijgevoort NCM, Del Chiaro M, Wolfgang CL, van Hooft JE, Besselink MG. Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines. Nat Rev Gastroenterol Hepatol. 2019;16:676-689. [PMID: 31527862 DOI: 10.1038/s41575-019-0195-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 13.7] [Reference Citation Analysis]
99 Springer S, Masica DL, Dal Molin M, Douville C, Thoburn CJ, Afsari B, Li L, Cohen JD, Thompson E, Allen PJ, Klimstra DS, Schattner MA, Schmidt CM, Yip-Schneider M, Simpson RE, Fernandez-Del Castillo C, Mino-Kenudson M, Brugge W, Brand RE, Singhi AD, Scarpa A, Lawlor R, Salvia R, Zamboni G, Hong SM, Hwang DW, Jang JY, Kwon W, Swan N, Geoghegan J, Falconi M, Crippa S, Doglioni C, Paulino J, Schulick RD, Edil BH, Park W, Yachida S, Hijioka S, van Hooft J, He J, Weiss MJ, Burkhart R, Makary M, Canto MI, Goggins MG, Ptak J, Dobbyn L, Schaefer J, Sillman N, Popoli M, Klein AP, Tomasetti C, Karchin R, Papadopoulos N, Kinzler KW, Vogelstein B, Wolfgang CL, Hruban RH, Lennon AM. A multimodality test to guide the management of patients with a pancreatic cyst. Sci Transl Med. 2019;11. [PMID: 31316009 DOI: 10.1126/scitranslmed.aav4772] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 26.0] [Reference Citation Analysis]
100 Majumder S, Taylor WR, Yab TC, Berger CK, Dukek BA, Cao X, Foote PH, Wu CW, Mahoney DW, Aslanian HR, Fernández-Del Castillo C, Doyle LA, Farrell JJ, Fisher WE, Lee LS, Lee YN, Park W, Rodrigues C, Gould Rothberg BE, Salem RR, Simeone DM, Urs S, Van Buren G, Smyrk TC, Allawi HT, Lidgard GP, Raimondo M, Chari ST, Kendrick ML, Kisiel JB, Topazian MD, Ahlquist DA. Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing. Am J Gastroenterol 2019;114:1539-49. [PMID: 31306149 DOI: 10.14309/ajg.0000000000000284] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
101 Gaujoux S, Coriat R. [Cystic lesion of the pancreas… The epidemic in yet not under control!]. Presse Med 2019;48:749-51. [PMID: 31303373 DOI: 10.1016/j.lpm.2019.05.027] [Reference Citation Analysis]
102 Dimaio CJ. Current Guideline Controversies in the Management of Pancreatic Cystic Neoplasms. Gastrointestinal Endoscopy Clinics of North America 2018;28:529-47. [DOI: 10.1016/j.giec.2018.05.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
103 Ånonsen K, Sahakyan MA, Kleive D, Waage A, Verbeke C, Hauge T, Buanes T, Edwin B, Labori KJ. Trends in management and outcome of cystic pancreatic lesions - analysis of 322 cases undergoing surgical resection. Scand J Gastroenterol 2019;54:1051-7. [PMID: 31322457 DOI: 10.1080/00365521.2019.1642379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
104 Girometti R, Pravisani R, Intini SG, Isola M, Cereser L, Risaliti A, Zuiani C. Evolution of incidental branch-duct intraductal papillary mucinous neoplasms of the pancreas: A study with magnetic resonance imaging cholangiopancreatography. World J Gastroenterol 2016; 22(43): 9562-9570 [PMID: 27920477 DOI: 10.3748/wjg.v22.i43.9562] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
105 Mel Wilcox C. Editorial: Management of the Small Asymptomatic Pancreatic Cyst: Somehow Along the Way We Forgot About the Patient. American Journal of Gastroenterology 2017;112:1337-9. [DOI: 10.1038/ajg.2017.188] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
106 Tomishima K, Sai JK, Kanazawa R, Miura H, Shimizu R, Sato K, Ishii S, Saito H, Ito T, Fukumura Y, Shiina S, Watanabe S. Impact of MUC1 Expression on the Progression of Intraductal Papillary Mucinous Neoplasm With Worrisome Features During Follow-up. Pancreas 2017;46:1127-32. [DOI: 10.1097/mpa.0000000000000902] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
107 Abe K, Kitago M, Masugi Y, Iwasaki E, Yagi H, Abe Y, Hasegawa Y, Fukuhara S, Hori S, Tanaka M, Nakano Y, Yokose T, Shimane G, Sakamoto M, Kitagawa Y. Indication for resection and possibility of observation for intraductal papillary mucinous neoplasm with high-risk stigmata. Pancreatology 2021;21:755-62. [PMID: 33632666 DOI: 10.1016/j.pan.2021.02.012] [Reference Citation Analysis]
108 Honselmann KC, Patino M, Mino-Kenudson M, Ferrone C, Warshaw AL, Castillo CF, Lillemoe KD. Ductal Carcinoma Arising in a Largely Unchanged Presumed Branch-duct IPMN After 10 Years of Surveillance. Ann Surg. 2017;266:e38-e40. [PMID: 28338512 DOI: 10.1097/sla.0000000000002238] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
109 Crippa S, Arcidiacono PG, De Cobelli F, Falconi M. Review of the diagnosis and management of intraductal papillary mucinous neoplasms. United European Gastroenterol J 2020;8:249-55. [PMID: 32213017 DOI: 10.1177/2050640619894767] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
110 Bassi C, Marchegiani G, Malleo G, Andrianello S, Salvia R. Comment on “Main Duct Dilatation Is the Best Predictor of High-grade Dysplasia or Invasion in Intraductal Papillary Mucinous Neoplasms of the Pancreas”. Annals of Surgery 2019;270:e108-9. [DOI: 10.1097/sla.0000000000003260] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
111 Roth S, Zamzow K, Gaida MM, Heikenwälder M, Tjaden C, Hinz U, Bose P, Michalski CW, Hackert T. Evolution of the immune landscape during progression of pancreatic intraductal papillary mucinous neoplasms to invasive cancer. EBioMedicine 2020;54:102714. [PMID: 32259711 DOI: 10.1016/j.ebiom.2020.102714] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
112 Farrell JJ. Pancreatic Cysts and Guidelines. Dig Dis Sci. 2017;62:1827-1839. [PMID: 28528374 DOI: 10.1007/s10620-017-4571-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
113 Dugnani E, Pasquale V, Liberati D, Citro A, Cantarelli E, Pellegrini S, Marra P, Canu T, Balzano G, Scavini M, Esposito A, Doglioni C, Piemonti L. Modeling the Iatrogenic Pancreatic Cancer Risk After Islet Autotransplantation in Mouse. Am J Transplant 2017;17:2720-7. [PMID: 28510280 DOI: 10.1111/ajt.14360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
114 Das KK, Geng X, Brown JW, Morales-Oyarvide V, Huynh T, Pergolini I, Pitman MB, Ferrone C, Al Efishat M, Haviland D, Thompson E, Wolfgang C, Lennon AM, Allen P, Lillemoe KD, Fields RC, Hawkins WG, Liu J, Castillo CF, Das KM, Mino-Kenudson M. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions. Gastroenterology 2019; 157: 720-730. e2. [PMID: 31175863 DOI: 10.1053/j.gastro.2019.05.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
115 Hata T, Dal Molin M, Suenaga M, Yu J, Pittman M, Weiss M, Canto MI, Wolfgang C, Lennon AM, Hruban RH, Goggins M. Cyst Fluid Telomerase Activity Predicts the Histologic Grade of Cystic Neoplasms of the Pancreas. Clin Cancer Res 2016;22:5141-51. [PMID: 27230749 DOI: 10.1158/1078-0432.CCR-16-0311] [Cited by in Crossref: 36] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
116 Crippa S, Pezzilli R, Bissolati M, Capurso G, Romano L, Brunori MP, Calculli L, Tamburrino D, Piccioli A, Ruffo G, Fave GD, Falconi M. Active Surveillance Beyond 5 Years Is Required for Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Non-Operative Management. Am J Gastroenterol 2017;112:1153-61. [PMID: 28244498 DOI: 10.1038/ajg.2017.43] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]